A look at the existing literature suggests more questions than answers remain when it comes to the potential use of the cholinergic anti-inflammatory pathway in connective tissue diseases (CTDs). The ...
A recent study posted to the bioRxiv* preprint server assessed the mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and Alpha variants of concern (VOCs) inhibit ...
Nicotinic and muscarinic ACh receptor agonists and acetylcholinesterase inhibitors (AChEls) can enhance cognitive function. However, it is unknown whether a common signaling pathway is involved in the ...
To study how a key chemical neuromodulator affects signaling in the brain's cortex, Garrett Neske, PhD, has received a three-year, $300,000 grant from the Whitehall Foundation, a nonprofit ...
Genomic Press Interview reveals Hebrew University Professor Soreq's groundbreaking research on acetylcholine and small RNA regulators in brain-body communication throughout the lifespan In a ...
Introduction Studies on human patellar and Achilles tendons have shown that tendon cells not only have the capacity to produce acetylcholine (ACh) but also express muscarinic ACh receptors (mAChRs), ...
Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the ...
Three the approved drugs for Alzheimer’s disease attempt to boost the brain’s supply of acetylcholine, a critical neurotransmitter for cognition that wanes in people with the disease. But might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback